Compare FBRX & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBRX | VTEX |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 755.3M |
| IPO Year | 2017 | 2019 |
| Metric | FBRX | VTEX |
|---|---|---|
| Price | $76.89 | $3.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $67.00 | $5.97 |
| AVG Volume (30 Days) | ★ 2.0M | 889.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | $12.78 |
| Revenue Next Year | N/A | $9.63 |
| P/E Ratio | ★ N/A | $43.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.18 | $2.84 |
| 52 Week High | $77.20 | $4.73 |
| Indicator | FBRX | VTEX |
|---|---|---|
| Relative Strength Index (RSI) | 84.38 | 38.91 |
| Support Level | $26.85 | $3.45 |
| Resistance Level | $77.20 | $3.79 |
| Average True Range (ATR) | 0.11 | 0.16 |
| MACD | -1.75 | -0.07 |
| Stochastic Oscillator | 88.64 | 18.67 |
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.